THC Global Group (ASX:THC) issued its quarterly update for the period ended on September 30, 2019.

As quoted in the press release:


Australian Cannabis Operations: Licenced Farm to Pharma

THC Global has secured Schedule 8 Controlled Substance (S8) and Schedule 4 Prescription Medicine (S4) Manufacturing and Wholesale Licences from the Queensland Department of Health for both the Company’s Southport Manufacturing Facility and its ‘Bundy’ Facility. These licences enable THC Global to hold, manufacture, and wholesale S8 and S4 substances and medicines including medicinal cannabis. These licences were a key requirement for the commencement of Australian supply and distribution of THC Global’s Australian produced medicinal cannabis as both S8 controlled medicines and S4 pharmacy medicines.

New Zealand CBD Products Sales: Shipment Sold Out

THC Global is the exclusive distributor of cannabidiol (CBD) products produced by Endoca, a European cannabis producer, in New Zealand. In support of the Company’s distribution activities of CBD products, the Company provided financial assistance to DATAPHARM, a healthcare company in New Zealand, to launch CBDinfo.co.nz (CBDinfo).

Click here to read the full press release.

In the news release, Harvest Health & Recreation Inc. to Hold First Quarter 2021 Earnings Conference Call on May 10, 2021 , issued 06-May-2021 by Harvest Health & Recreation Inc. over PR Newswire, we are advised by the company that the 1st paragraph, 1st sentence, should read “8:00AM Eastern Time” rather than “5:00 AM Eastern Time” as originally issued inadvertently. The complete, corrected release follows:

Harvest Health & Recreation Inc. to Hold First Quarter 2021 Earnings Conference Call on May 10, 2021

Keep reading... Show less

Harvest Health & Recreation Inc. ( CSE: HARV OTCQX: HRVSF ) (“Harvest”), a vertically integrated cannabis company and multi-state operator in the U.S., today announced that it will hold a conference call on Monday, May 10, 2021 at 5:00 AM Eastern Time following the release of its first quarter 2021 financial results.

Keep reading... Show less

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF)( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe is pleased to announce that Chairman Chris Naprawa will present live at Canaccord Genuity’s 2021 Virtual Cannabis Conference on Tuesday, May 11, 2021 at 1:00 p.m. EDT ( 10:00 a.m. PDT ).

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf”, “OILS”, or the “Company”), the world’s most innovative cannabis extractor, is pleased to announce the following updates around its CBD business:

Keep reading... Show less